Venous thromboembolism (VTE) is the third most common cause of vascular mortality
worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In …

Chronic thromboembolic pulmonary hypertension anno 2021 : Current Opinion in Cardiology
Chronic thromboembolic pulmonary hypertension anno 2021 : Current Opinion in Cardiology …

Background and aim Chronic thromboembolic pulmonary hypertension (CTEPH) is caused
by the obstruction of the main pulmonary artery due to thrombosis and vascular remodeling …

Background Venous thromboembolism is one of the major public health problems in the
world. Though several studies were conducted to estimate common risk factors of venous …

Background: To explore the role of gender in the incidence of chronic thromboembolic
pulmonary hypertension after acute pulmonary embolism. Methods: Two researchers search …

Venous thromboembolism (VTE) is a life-threatening disease with risk of recurrence. Oral
anticoagulation (OAC) with vitamin K antagonists (VKA) is effective to prevent …

Хроническая тромбоэмболическая легочная гипертензия (ХТЭЛГ) является тяжелой и
недостаточно диагностируемой патологией, которая приводит к развитию …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe and underdiagnosed
disorder that leads to right ventricular failure and, subsequently, to death. The article …

While most of the world mobilized the medical research community to battle coronavirus
disease-2019 (COVID-19), there were several important, clinically relevant publications in …

The second author's initials also appear incorrectly in the citation. The correct citation is:
Boon GJAM, van Rein N, Bogaard HJ, Ende-Verhaar YM, Huisman MV, Kroft LJM, et …